Hair & Nail Benefit
Size: 60 Vegetarian Capsules
Targeted Nutritional Formula for Thicker Hair and Stronger Nails*
Please select all options.
Hair & Nail Benefit is your best weapon against thinning hair, brittle nails, and signs of aging skin. With a high-quality, research-backed blend of choline, silicon and biotin, this product helps to naturally nourish your body’s beauty proteins from the inside out.
- Thickens and Strengthens Hair and Nails*
- Reduces Skin Lines and Wrinkles*
- Promotes Skin Elasticity*
- Supports Bone Tissue Formation*
- Promotes Healthy Collagen and Joint Tissue*
Hair loss, brittle nails, and skin damage can occur for many reasons, including toxin exposures, nutritional deficiencies, hormone changes, infections, and genetics. While it is important to investigate underlying causes with a healthcare professional, Hair & Nail Benefit can provide targeted symptomatic support for everyday self-care. Plus, it’s great for anyone who wants thicker, more luscious hair, strong nails and smoother, softer skin!*
Hair & Nail Benefit features three key ingredients for tissue support:
- Silicon is necessary for the formation of collagen and other proteins that strengthen bones, connective tissue, and healthy nails, skin, and hair.*
- Choline is an essential nutrient involved in synthesizing fatty acids to maintain strong cell membranes, keeping our hair, nails and skin flexible and smooth.*
- Biotin supports cell growth, fatty acid production, and the utilization of other B-Complex vitamins for tissue regeneration.*
Hair & Nail Benefit features silicon and choline as Choline-Stabilized Orthosilicic Acid. This formulation increases bioavailability for synergistic benefits that have been demonstrated in numerous clinical studies.3-6 In addition, both silicon and choline play proven roles in memory and cognitive function,7-8 making Hair & Nail Benefit a powerful support for youthful living!*
*These statements have not been evaluated by the FDA and are not intended to treat or cure any disease.
We know it works!
Many of The Morrison Center staff members use Hair & Nail Benefit and have seen major transformations in their hair, nails and skin. It’s one of our most popular supplements for a reason!
Research shows it works, too
Four randomized clinical studies have found that choline-stabilized orthosilicic acid, featured in Hair & Nail Benefit, can increase bone mineral density, hair thickness, and nail strength, while reducing wrinkles and improving skin texture when taken daily
1 CAPSULE PER SERVING
Biotin 5000 mcg
Choline (as choline-stabilized orthosilicic acid) 100 mg
Silicon (as choline-stabilized orthosilicic acid) 5 mg
Other Ingredients: Capsule (hypromellose and water), microcrystalline cellulose, and purified water.
FORMULATED TO EXCLUDE: Wheat, gluten, corn, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, GMOs, artificial colors, artificial sweeteners, and preservatives
Take 1 capsule two times per day, or as directed by your healthcare practitioner.
Caution: Consult your healthcare professional prior to use. Individuals taking medication should discuss potential interactions with their healthcare practitioner.
Chronic exposure of the skin to sunlight causes damage to the underlying connective tissue with a loss of elasticity and firmness. Silicon (Si) was suggested to have an important function in the formation and maintenance of connective tissue. Choline-stabilized orthosilicic acid ("ch-OSA") is a bioavailable form of silicon which was found to increase the hydroxyproline concentration in the dermis of animals. The effect of ch-OSA on skin, nails and hair was investigated in a randomized, double blind, placebo-controlled study. Fifty women with photodamaged facial skin were administered orally during 20 weeks, 10 mg Si/day in the form of ch-OSA pellets (n=25) or a placebo (n=25). Noninvasive methods were used to evaluate skin microrelief (forearm), hydration (forearm) and mechanical anisotropy (forehead). Volunteers evaluated on a virtual analog scale (VAS, "none=0, severe=3") brittleness of hair and nails. The serum Si concentration was significantly higher after a 20-week supplementation in subjects with ch-OSA compared to the placebo group. Skin roughness parameters increased in the placebo group (Rt:+8%; Rm: +11%; Rz: +6%) but decreased in the ch-OSA group (Rt: -16%; Rm: -19%; Rz: -8%). The change in roughness from baseline was significantly different between ch-OSA and placebo groups for Rt and Rm. The difference in longitudinal and lateral shear propagation time increased after 20 weeks in the placebo group but decreased in the ch-OSA group suggesting improvement in isotropy of the skin. VAS scores for nail and hair brittleness were significantly lower after 20 weeks in the ch-OSA group compared to baseline scores. Oral intake of ch-OSA during the 20 weeks results in a significant positive effect on skin surface and skin mechanical properties, and on brittleness of hair and nails.
Background: Mounting evidence supports a physiological role for silicon (Si) as orthosilicic acid (OSA, Si(OH)4) in bone formation. The effect of oral choline-stabilized orthosilicic acid (ch-OSA) on markers of bone turnover and bone mineral density (BMD) was investigated in a double-blind placebo-controlled trial.
Methods: Over 12-months, 136 women out of 184 randomized (T-score spine < -1.5) completed the study and received, daily, 1000 mg Ca and 20 microg cholecalciferol (Vit D3) and three different ch-OSA doses (3, 6 and 12 mg Si) or placebo. Bone formation markers in serum and urinary resorption markers were measured at baseline, and after 6 and 12 months. Femoral and lumbar BMD were measured at baseline and after 12 months by DEXA.
Results: Overall, there was a trend for ch-OSA to confer some additional benefit to Ca and Vit D3 treatment, especially for markers of bone formation, but only the marker for type I collagen formation (PINP) was significant at 12 months for the 6 and 12 mg Si dose (vs. placebo) without a clear dose response effect. A trend for a dose-corresponding increase was observed in the bone resorption marker, collagen type I C-terminal telopeptide (CTX-I). Lumbar spine BMD did not change significantly. Post-hoc subgroup analysis (baseline T-score femur < -1) however was significant for the 6 mg dose at the femoral neck (T-test). There were no ch-OSA related adverse events observed and biochemical safety parameters remained within the normal range.
Conclusion: Combined therapy of ch-OSA and Ca/Vit D3 had a potential beneficial effect on bone collagen compared to Ca/Vit D3 alone which suggests that this treatment is of potential use in osteoporosis. NTR 1029.